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Endocrine and metabolic mechanisms of embryo and fetal intrauterine growth
retardation in dairy cows
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Abstract: This research was conducted to study hormonal and metabolic statuses and to determine ultrasound criteria for early
diagnosis of fetal growth retardation syndrome (FGRS) in dairy cows of Black-motley (n = 41) and Red-motley (n = 56) Holstein
breeds. Concentrations of progesterone, testosterone, 17β-estradiol, dehydroepiandrosterone sulfate, cortisol, and triiodothyronine in
blood serum were assessed by immune-enzyme analysis. Concentrations of plasma L-ascorbic acid and nitrogen oxides, serum immune
globulin, middle molecular peptides, and bactericidal and lysozyme activity were determined by spectrophotometry. On days 38–40 and
60–65 of gestation, FGRS in cows was associated with hypoprogesteronemia, decrease of adrenal and thyroid gland functions, decreased
nitric oxide synthesis, low immune responsiveness, and high endogenous intoxication. In conclusion, body length less than 16 mm on
days 38–40 and less than 45 mm on days 60–65 are the criteria for designating underdevelopment of embryos and fetuses in dairy cows.
FGRS genesis in dairy cows is determined by the embryo’s and fetus’s malnutrition at the early implantation and placentation stages,
caused by the imbalance of endocrine regulation, nitric oxide systems, and endogenous intoxication.
Key words: Fetal growth retardation syndrome, cow, ultrasound diagnostics, hormones, nitrogen oxides, L-ascorbic acid

1. Introduction
Potential increase in efficiency in modern dairy husbandry
can result from decreases in antenatal and neonatal losses.
One detriment to increased efficiency is embryo and fetal
intrauterine growth retardation (FGRS), an inadequacy
of sizes at specific periods of gestation. This pathology
is rather widespread in both scientific literature and
clinical practice and is an important cause for perinatal
morbidity and fetal and litter mortalities (1–3). Moreover,
manifestation of this syndrome has a negative impact
on subsequent reproductive function of the dam (2) and
postnatal formation and function of neonates’ organs
and digestive, respiratory, and reproductive systems,
predisposing these animals to metabolic and endocrine
diseases and decreased fertility (1,3–5).
The mechanisms leading to disorders in formation and
growth processes in the embryo and fetus are determined
mainly by nutrition provided during the first stages from
endometrial gland secretory activity (6,7) and by the
intensity of vascularization in the placenta and utero* Correspondence: cherae@mail.ru

placental blood circulation in the transition to placental
circulation (1,8–10). However, inadequate knowledge
regarding the role of the metabolic homeostasis of the
mother to provide adequate formation of the mother–
embryo–placenta–fetus
biological
system
limits
development of methods for managing these processes.
Thus, the current research aimed to achieve early diagnosis
of FGRS and to determine the role of hormonal and
metabolic statuses of cows in the genesis of this pregnancy
failure.
2. Materials and methods
2.1. Animal materials and study design
The research was performed during winter when cattle
were stalled indoors. The study included cows of Blackmotley (n = 41) and Red-motley (n = 56) Holstein breeds
with an average annual milk production of 6500–7500
kg. Rations contained matched mono-fodders prepared
according to the normative standards for animals’ needs
in essential nutrients and vitamin-mineral supplements. A
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total of 97 cows were used: 56 at days 38–40 and 41 at days
60–65 of gestation. The methods of transrectal palpation
and echography with the use of ultrasound scanner EasiScan-3 with a linear transducer of 4.5–8.5 MHz (BCF
Technology Ltd., UK) were applied for the measurement
of genitals and embryos’ and fetuses’ metrical indices.
Size and consistency of the parous uterine horn and the
embryo’s coccyx–parietal distance and diameter of the
embryo were measured. Generalized literature and our
own research data were used for estimating fetometric
indices (11–13).
2.2. Collection of samples
After clinico-echographic examination, blood samples
were taken via puncture of the jugular vein in 13 cows
(5 Black-motley and 8 Red-motley animals) with normal
physiological course of gestation and 16 cows (6 Blackmotley and 10 Red-motley animals) with FGRS. These
cows were sampled again at days 230–240 of gestation.
Blood was collected into sterile vacuum tubes without
anticoagulant or with EDTA to obtain blood plasma by
centrifugation of the stabilized blood EDTA at 4000 × g
for 10 min (UC-1612, ULAB, China) at room temperature.
After clotting for 1 h at room temperature, blood samples
without anticoagulant were centrifuged (UC-1612, ULAB)
at 4000 × g for 10 min at room temperature, and sera were
harvested carefully and stored at –20 °C until biochemical
analyses.
2.3. Biochemical analyses
Quantitative analysis of progesterone, testosterone,
17β-estradiol, dehydroepiandrosterone sulfate (DHEAS),
cortisol, and triiodothyronine in serum was conducted by
immune-enzyme analysis test systems validated for cattle
(Xema-Medica Co. Ltd., Russia) and an immunoenzyme
reaction analyzer (Uniplan, AIFR-1, Pikon, Russia).
Quantitative analysis of L-ascorbic acid and nitrogen
oxides (NOx = NO2- + NO3-) in plasma and middle
molecular peptides and immune globulin in serum was
conducted by spectrophotometry (UV-1700, Shimadzu,
Japan) according to the procedure modified from the
relevant literature (14–17).
2.4. Analysis of serum bactericidal and lysozyme activity
Bactericidal and lysozyme activity of serum was evaluated
according to the modified method of Voronin et al. (18).
For the study of serum bactericidal activity, 1 mL of serum
and 0.1 mL of 24-h Escherichia coli broth culture were
added into 4.5 mL of Hottinger broth (test samples). Only
microorganism culture was added to control samples.
Tube contents were carefully agitated, 2 mL of the mixture
was selected, and its optical density was determined at
490 nm (UV-1700, Shimadzu). The mixture left in the
tubes was incubated at 37 °C (TS-1-80 SPU, Smolenskoye
SKTB, Russia) for 3 h, and its optical density was measured
repeatedly. Bactericidal activity of blood serum was

676

expressed in optical density growth inhibition units in
test samples in comparison with control samples (%). For
quantitative analysis of serum lysozyme activity, tabulated
values of dependence between lysozyme concentration
and its lytic action on Micrococcus lysodeikticus culture,
slurried in 0.06 M phosphate buffer (pH 7.2–7.4), were
used (19).
2.5. Statistical analysis
For statistical analysis, the independent sample t-test
was used to determine the difference between the values
obtained from control (physiological gestation course) and
FGRS groups. Statistical evaluation of differences between
cows with gestation periods of 38–40, 60–65, and 230–240
days was done using the paired t-test in STATISTICA 8.0
(StatSoft. Inc., USA). Statistical significance was set at P <
0.05. All data were expressed as mean ± standard error of
the mean (SEM).
3. Results
3.1. Metric values of embryo and fetus
Fetal growth retardation occurred in 36.7% of the Blackmotley cows (n = 41) and in 42.9% of the Red-motley cows
(n = 56). The maximum manifestation of this pathology
was observed in first-lactation cows (45.0% in Blackmotley cows and 54.5% in Red-motley cows), and the
minimum manifestation was observed in cows in their
third or above lactation (27.3% in Black-motley cows and
28.6% in Red-motley cows).
From Table 1, embryos with growth retardation at
38–40 days had linear sizes of 67.3% (13.8 ± 0.37 mm, P
< 0.001) and corpus diameters of 72.3% (8.1 ± 0.42 mm,
P < 0.001) of those of the controls. At the transition into
fetal stage (60–65 days), the norm was characterized by
linear sizes increasing 3.32 times to 68.1 ± 4.48 mm (P <
0.001) and corpus diameter increasing 1.68 times to 18.8 ±
2.35 mm (P < 0.001). The length of embryos with retarded
growth processes was 77.8% of the length of the normally
developing embryos (P < 0.001).
Fetal growth retardation among examined Blackmotley breed cows (n = 41) was registered in 36.7% of
them and among Red-motley breed cows (n = 56) in 42.9%
of animals. The maximum manifestation of this pathology
was marked in cows of the first lactation (45.0% in Blackmotley breed cows and 54.5% in Red-motley breed cows)
and the minimum manifestation of this pathology was
marked in cows of the third or above lactations (27.3% in
Black-motley breed cows and 28.6% in Red-motley breed
cows).
3.2. Hormonal status
Concentration of progesterone in serum of cows with
FGRS in comparison with the animals of the control group
(physiological gestation course) appeared to be lower by
35.3% (P < 0.01) (Table 2).
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Table 1. Metric values of embryos and fetuses of the cows with physiological gestation course and FGRS.
Gestation period of 38–40 days

Gestation period of 60–65 days

Control group
Mean ± SEM
(min–max)
(n = 31)

FGRS group
Mean ± SEM
(min–max)
(n = 25)

Control group
Mean ± SEM
(min–max)
(n = 24)

FGRS group
Mean ± SEM
(min–max)
(n = 17)

Coccyx–parietal size, mm

20.5 ± 0.66
(18–25)

13.8 ± 0.37c
(12–16)

68.1 ± 4.48
(50–80)

38.3 ± 2.48c
(25–45)

Corpus diameter, mm

11.2 ± 0.59
(10–13)

8.1 ± 0.42c
(7–9)

18.8 ± 2.35
(17–24)

14.6 ± 0,67c
(12–16)

Parameters

Statistical importance between control and FGRS groups: cP < 0.001.
Table 2. The levels of hormones in blood serum in physiological gestation course and FGRS.
Parameters

Gestation period of 38–40
days Mean ± SEM

Gestation period of 60–65
days Mean ± SEM

Gestation period of 230–240
days Mean ± SEM

Progesterone (nmol/L)

13.9 ± 1.15
9.0 ± 0.79b

24.9 ± 1.58***
18.7 ± 1.80a***

10.8 ± 0.76
16.4 ± 1.00c

Testosterone (nmol/L)

1.46 ± 0.104
1.68 ± 0.190

1.57 ± 0.123
1.41 ± 0.052

2.43 ± 0.254
1.92 ± 0.062c

17β-estradiol (nmol/L)

0.32 ± 0.031
0.43 ± 0.024

0.49 ± 0.042c***
0.23 ± 0.013***

0.96 ± 0.073
0.54 ± 0.020c

DHEAS (µg/ml)

0.11 ± 0.010
0.18 ± 0.013

0.19 ± 0.011***
0.13 ± 0.012c***

0.26 ± 0.013
0.23 ± 0.010c

Cortisol (nmol/L)

6.34 ± 1.762
5.30 ± 0.410

15.70 ± 1.224***
3.44 ± 0.320c*

12.00 ± 0.824
6.50 ± 0.581c

Triiodothyronine (nmol/L)

3.98 ± 0.323
3.72 ± 0.284

7.98 ± 0.642***
2.56 ± 0.221c**

5.12 ± 0.260
2.92 ± 0.150c

Above the line: control group (n = 13), under the line: FGRS group (n = 16).
Statistical importance between control and FGRS groups: aP < 0.05, bP < 0.01, cP < 0.001.
Statistical importance between gestation periods of 38–40 and 60–65 days: *P < 0.05, **P < 0.01, ***P < 0.001.

In cows with normal course of physiological gestation,
the embryo’s transition into fetal development (60–65
days) in comparison to 38–40 days was accompanied by
increased endocrine gland function: 79.1% in progesterone
(P < 0.001), 53.1% in 17β-estradiol (P < 0.001), 147.6%
in cortisol (P < 0.001), 72.7% in DHEAS (P < 0.001),
and 100.5% in triiodothyronine (P < 0.001). Although
progesterone concentration in cows with FGRS increased
by 107.8% (P < 0.001), the other hormones, which are
responsible for protein synthesis, bone formation, and
proliferative changes in cows’ uterine tissues, decreased:
17β-estradiol to 46.5% (P < 0.001), cortisol to 35.1% (P <
0.05), DHEAS to 27.8% (P < 0.001), and triiodothyronine
to 31.2% (P < 0.01), respectively, in comparison with 38–40
days of gestation. Thus, the concentration was lower for
progesterone by 24.9% (P < 0.05), 17β-estradiol by 53.1%

(P < 0.001), cortisol by 78.1% (P < 0.001), DHEAS by 31.6%
(P < 0.001), and triiodothyronine by 67.9% (P < 0.001) in
blood serum of cows with FGRS on days 60–65 of gestation
in comparison with the animals of the control group.
The concentrations of cortisol, DHEAS, 17β-estradiol,
and testosterone in serum of cows with FGRS during the
final gestation period (230–240 days) appeared to be 45.8%
(P < 0.001), 11.5% (P < 0.001), 43.8% (P < 0.001), and
21.0% (P < 0.001) lower, respectively, than in the control
group level. Progesterone concentration in serum of cows
with FGRS, on the contrary, was 51.9% (P < 0.001) higher
than in the controls. The progesterone/17β-estradiol ratio
was 30.4 in FGRS cows to 11.2 in cows with physiological
course of gestation. In addition, cows with FGRS had
decreased (P < 0.001) triiodothyronine concentration,
which was 57.0% of that of controls.
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3.3. Immunological and biochemical indices
Cows with FGRS had 75.5% of the L-ascorbic acid in
plasma on days 38–40 (P < 0.05), 76.7% on days 60–65 (P <
0.01), and 75.9% on days 230–240 (P < 0.01) of that in the
control group. L-ascorbic acid decrease in the cows with
FGRS also had a negative impact on their immunological
status indices (Table 3); serum lysozyme activity in cows
with FGRS was 60.7% (P < 0.01) at the stage of active
embryo, 80.9% at the fetogenesis stage (P < 0.05), and
87.2% at the end of gestation (P < 0.05) compared to the
control group. Serum immune globulin level in cows with
FGRS throughout the gestation period was 19.0%–10.2%
lower (P < 0.05) in comparison with the control group.
Concentration of nitrogen oxides in serum was lower
(76.1%, P < 0.05) in cows with FGRS at the placentation
stage (days 60–65) in comparison to the control group.
Nitrogen oxide concentrations in blood serum of cows
with FGRS at the final gestation stage, on the contrary,
increased by 19.9% (P < 0.05) in comparison with the
control group.
Significant increase of middle molecular peptides level
in serum of cows with FGRS [by 28.6–50.0% (P < 0.001) in
comparison with the indices of the control group] marked
the presence of endogenous intoxication and activation of
proteolysis processes.
4. Discussion
Embryo and fetal intrauterine growth retardation in cows
is a polyfactorial syndrome (1,20), which is defined as
an inadequacy of forming embryos and fetuses and their
gestation periods. Clinical method of genital organ state

evaluation (13) is used for FGRS diagnosis in pregnant
cows. The results of the current research showed that the
accuracy of FGRS diagnosis in pregnant cows significantly
increased by determining the embryo’s coccyx–parietal
size by ultrasonography. On the basis of the literature
(11,12) and the results of the present study, body length less
than 16 mm on days 38–40 and less than 45 mm on days
60–65 are the criteria for designating underdevelopment
of embryos and fetuses in cows.
It is conventional to think that the processes of the
embryo’s growth and development in cows are regulated
mainly by the character of the maternal nutrition,
metabolic homeostasis, and maternal genital organs state
(1,21,22). The current work accentuated genetic factors.
The results show that the leading role in FGRS forming
belongs to the nutritional factors of the forming embryo,
its immunotrophic interaction with the mother’s organism,
and endogenous intoxication state.
At the early stages of embryo formation, growth
retardation is connected with hypoprogesteronemia,
determined by hypoplasia of the yellow body. Clinicoechographic data proved it. Thus, yellow body size in FGRS
cows appeared to be 75.8% (13.8 ± 0.59 mm, P < 0.001)
on days 38–40 and 79.0% (16.2 ± 0.59 mm, P < 0.001) on
days 60–65 of gestation in comparison with controls. On
one hand, progesterone deficit does not provide optimal
secretory reaction of the uterine glands and the conditions
for balanced nutrition and the embryo’s implantation.
On the other hand, it promotes aggressive increase of
peripheral monocytes and lymphocytes in relation to both
the embryo’s tissues and the further forming placenta (7).

Table 3. Plasma L-ascorbic acid and nitrogen oxides levels, serum bactericidal activity, lysozyme activity, serum immune globulin, and
middle molecular peptides of cows with FGRS and control groups.
Parameters

Gestation period of 38–40
days Mean ± SEM

Gestation period of 60–65
days Mean ± SEM

Gestation period of 230–240
days Mean ± SEM

L-ascorbic acid (µmol/L)

23.3 ± 1.36
17.6 ± 1.16a

23.2 ± 0.87
17.8 ± 0.91b

16.2 ± 0.93
12.3 ± 0.66b

Nitrogen oxides (µmol/L)

95.2 ± 3.90
101.2 ± 5.40

132.4 ± 10.80
100.7 ± 8.70a

75.7 ± 5.14
90.8 ± 6.25a

Serum bactericidal activity (%)

83.3 ± 2.42
77.9 ± 3.15

80.2 ± 3.22c
75.5 ± 2.60

75.4 ± 3.92
69.1 ± 2.75c

Serum lysozyme activity (µg/mL)

0.56 ± 0.021
0.34 ± 0.010b

0.68 ± 0.042
0.55 ± 0.031a

0.78 ± 0.022
0.68 ± 0.030a

Immune globulin (g/L)

29.4 ± 1.84
23.8 ± 0.89a

29.2 ± 1.48
27.4 ± 1.72a

32.2 ± 1.90
28.9 ± 2.11a

Middle molecular peptides (OD 210)

0.40 ± 0.02
0.56 ± 0.03c

0.56 ± 0.02
0.72 ± 0.03c

0.40 ± 0.01
0.60 ± 0.02c

Above the line: control group (n = 13), under the line: FGRS group (n = 16).
Statistical importance between control and FGRS groups: aP < 0.05, bP < 0.01, cP < 0.001.
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Besides functional insufficiency of sexual glands in cows
with FGRS, adrenal and thyroid gland function decreased,
leading to hormonal imbalance.
At the stage of placentation the role of the embryo’s
nutrition belongs to placenta vascularization processes
and uteroplacental blood circulation formation (1,8,10),
the key regulator of which is nitric oxide (10,23–25).
The current research demonstrated that the cows with
FGRS at the stage of placentation had an evident NO·
deficit, which was proved by the decrease by 23.9% of its
stable metabolites concentration (NO2- + NO3-) in blood
serum (P < 0.05) in comparison with the control group
(physiological gestation course). Decreased NO· synthesis
decelerates placental–embryonic blood flow, disturbs
nutrient and oxygen transfer to the fetus, and restrains its
growth (24).
A significant decrease of L-ascorbic acid level in blood
plasma was observed throughout the whole research by
23.3%–24.5% in comparison with the animals from the
control group. The decrease of the organism’s provision
with vitamin C had a negative impact on the immune
status indices of the cows with FGRS, and in the first place
on serum lysozyme activity, reflecting the functional state
of the neutrophils. Serum lysozyme activity in cows with
FGRS was significantly lower than the mean values in the
control group throughout the whole gestation. Vitamin C
also provides antioxidative protection for the developing
embryo and fetus (26), and participates in the processes
of the forming embryo’s connective tissue (27,28). Thus,
the decrease of its level in pregnant animals should be
considered as an extremely unfavorable factor for the
embryo’s and fetus’s development.
The results showed that a significant role in FGRS
pathogenesis in cows belongs to endogenous intoxication,

with a significant (1.3–1.5 times) increase of middle
molecular peptides concentrations in blood serum in
comparison with the control group (P < 0.001). Middle
molecular peptides are formed as a result of proteolysis
of serum and tissue proteins, and their levels in blood
serum depend on both the state of detoxication systems
and the activity of proteolysis processes. Being molecular
analogs of regulatory peptides, short-chain peptides are
capable of blocking cell membrane receptors, decreasing
transporting abilities of albumin, and disturbing many
metabolic processes (29). Moreover, endogenous
intoxication can exhaust adaptive resources of cellular and
humoral immunity (30) that we have registered in cows
with FGRS.
Thus, the realization of the genetic programing and
the fetus’s development in dairy cows to a large extent is
determined by the level of synthesis and metabolism of
the sex hormones, corticosteroids, and thyroid hormones,
which are specialized regulators of the biochemical and
biophysical processes in the mother’s and fetus’s organisms.
The key moment in the fetus’s growth retardation syndrome
formation is fetal malnutrition at the stage of implantation
and early placentation, connected with incompleteness of
endometrium secretory transformation and placental–
embryonic blood flow, caused by the imbalance in sex
steroid synthesis and the nitric oxide system. Decreased
immunobiological reactivity level of the mother’s
organism and endogenous intoxication state appear as
the determining factors causing functional insufficiency
development in the forming biological mother–fetus
system. The revealed pathogenetic mechanisms of
formation, growth, and development disorders of the
embryo and fetus may be the basis for developing effective
prophylaxis and therapy strategies in cows with FGRS.
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